- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jacobio Pharmaceuticals Group Co Lt (1167)
Jacobio Pharmaceuticals Group Co Lt stock price live, this page displays HK 1167 stock exchange data. View the 1167 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jacobio Pharmaceuticals Group Co Lt real time stock price chart below.
What Is the Jacobio Pharmaceuticals Group Co Lt Stock Price Today?
The Jacobio Pharmaceuticals Group Co Lt stock price today is 7.39.
What Is the Stock Symbol for Jacobio Pharmaceuticals Group Co Lt?
The stock symbol for Jacobio Pharmaceuticals Group Co Lt is ""1167.""
What Stock Exchange Does Jacobio Pharmaceuticals Group Co Lt Trade On?
Jacobio Pharmaceuticals Group Co Lt is listed and trades on the Hong Kong stock exchange.
Is Jacobio Pharmaceuticals Group Co Lt a Good Stock to Buy?
Determining whether Jacobio Pharmaceuticals Group Co Lt—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1167 quote. (ISIN: KYG4987A1094)
What Is the Jacobio Pharmaceuticals Group Co Lt Stock Price Today?
The Jacobio Pharmaceuticals Group Co Lt stock price today is 7.39.
What Is the Stock Symbol for Jacobio Pharmaceuticals Group Co Lt?
The stock symbol for Jacobio Pharmaceuticals Group Co Lt is ""1167.""
What Stock Exchange Does Jacobio Pharmaceuticals Group Co Lt Trade On?
Jacobio Pharmaceuticals Group Co Lt is listed and trades on the Hong Kong stock exchange.
Is Jacobio Pharmaceuticals Group Co Lt a Good Stock to Buy?
Determining whether Jacobio Pharmaceuticals Group Co Lt—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1167 quote. (ISIN: KYG4987A1094)
Hong Kong
Currency in HKD
7.39
-0.55(-6.93%)
Closed·
Fair Value
An estimate of a Jacobio Pharmaceuticals Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.20
8.14
52 wk Range
1.20
9.55
1167 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
1167 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Jacobio Pharmaceuticals Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.208.14
52 wk Range
1.209.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1167 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Jacobio Pharmaceuticals Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
5.30
Downside
-28.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Jacobio Pharma Announces 2024 Annual Results
- Investing.com
- Jacobio Pharma Announces 2024 Annual Results
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Jacobio Pharmaceuticals Group Co Lt Company Profile
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies. Its clinical stage candidates include Glecirasib (JAB-21822), a KRAS G12C inhibitor under multiple stage studies for indications such as NSCLC, PDAC, CRC, and other solid tumors; Sitneprotafib (JAB-3312), an SHP2 inhibitor that is in Phase III trials for NSCLC indication; JAB-23E73, a Pan-KRAS inhibitor for indications including NSCLC, PDAC, CRC, and other solid tumors; JAV-8263, a BET inhibitor for solid and liquid tumors; JAB-2485 Aurora A inhibitor, JAB-30355 P53 Y220C inhibitor, JAB-BX102 CD73 mAb inhibitor, JAB-26766 PARP 7 inhibitor, and JAB-BX300 LIF inhibitor under trials for solid tumor indications; and JAB-24114, a glutamine-utilizing enzyme for solid tumor and hematological malignancy indications. The company also develops IND-enabling candidates, including JAB-BX467, JAB-BX600, and JAB-BX700 for solid tumor indications. It has a collaboration agreement with Merck for cetuximab for combination trials. Jacobio Pharmaceuticals Group Co., Ltd. was founded in 2015 and is headquartered in Beijing, China.
Compare 1167 to Peers and Sector
Metrics to compare | 1167 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1167PeersSector | |
|---|---|---|---|---|
P/E Ratio | −36.8x | −16.1x | −0.5x | |
PEG Ratio | −0.61 | 0.29 | 0.00 | |
Price/Book | 6.2x | 6.3x | 2.6x | |
Price / LTM Sales | 36.8x | 23.6x | 3.3x | |
Upside (Analyst Target) | −29.5% | −0.6% | 43.5% | |
Fair Value Upside | Unlock | −7.3% | 6.9% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 5.30
(-28.32% Downside)
Earnings
Latest Release
Apr 24, 2025
EPS / Forecast
0.02 / -0.34
Revenue / Forecast
155.71M / --
FAQ
What Stock Exchange Does Jacobio Pharmaceuticals Group Trade On?
Jacobio Pharmaceuticals Group is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Jacobio Pharmaceuticals Group?
The stock symbol for Jacobio Pharmaceuticals Group is "1167."
What Is the Jacobio Pharmaceuticals Group Market Cap?
As of today, Jacobio Pharmaceuticals Group market cap is 6.26B.
What Is Jacobio Pharmaceuticals Group's Earnings Per Share (TTM)?
The Jacobio Pharmaceuticals Group EPS (TTM) is -0.20.
From a Technical Analysis Perspective, Is 1167 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Jacobio Pharmaceuticals Group Stock Split?
Jacobio Pharmaceuticals Group has split 0 times.
How Many Employees Does Jacobio Pharmaceuticals Group Have?
Jacobio Pharmaceuticals Group has 257 employees.
What is the current trading status of Jacobio Pharmaceuticals Group (1167)?
As of 07 Aug 2025, Jacobio Pharmaceuticals Group (1167) is trading at a price of 7.39, with a previous close of 7.94. The stock has fluctuated within a day range of 7.20 to 8.14, while its 52-week range spans from 1.20 to 9.55.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.